← Back to patent-cliff list
CAS 883231-14-9
(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)boronic acid
Codes: TEDI-016
Application context (from source-drug indications)
Skin and skin structure infectionTedizolid PhosphateStaphylococcal infectionTedizolid PhosphateBacterial skin diseaseTedizolid Phosphate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Tedizolid Phosphate | Tier C — Watch / trade | 2029 |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(R)-3-(3-fluoro-4-iodophenyl)-5-(hydroxymethyl)oxazolidin-2-one→5-bromo-2-(2H-tetrazol-5-yl)pyridine→2-fluoro-1-iodo-4-isocyanatobenzene→(R)-oxiran-2-ylmethyl 4-methylbenzenesulfonate→(R)-(3-(3-fluoro-4-iodophenyl)-2-oxooxazolidin-5-yl)methyl methanesulfonate→(R)-(3-(3-fluoro-4-iodophenyl)-2-oxooxazolidin-5-yl)methyl dihydrogen phosphate→(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)boronic acid→dimethyl (6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)boronate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.